adenine and 6-methyl-2-(phenylethynyl)pyridine

adenine has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambrosi, G; Antoninetti, G; Baqi, Y; Blandini, F; Cerri, S; Costa, G; Fuzzati-Armentero, MT; Levandis, G; Montepeloso, E; Müller, CE; Pinna, A; Simola, N; Volpini, R	1

Other Studies

1 other study(ies) available for adenine and 6-methyl-2-(phenylethynyl)pyridine

Article	Year
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease. Journal of neurochemistry, 2015, Volume: 134, Issue:4 Topics: Adenine; Animals; Drug Delivery Systems; Drug Synergism; Levodopa; Male; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Purinergic P1 Receptor Antagonists; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Rotation; Treatment Outcome; Xanthines	2015

Article

Year

Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease.

Journal of neurochemistry, 2015, Volume: 134, Issue:4

Topics: Adenine; Animals; Drug Delivery Systems; Drug Synergism; Levodopa; Male; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Purinergic P1 Receptor Antagonists; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Rotation; Treatment Outcome; Xanthines

2015